High membrane expression of CD163 by bone marrow cells is not a specific marker of macrophage activation syndrome (MAS) by Bracaglia, C et al.
BioMed  Central
Page 1 of 1
(page number not for citation purposes)
Pediatric Rheumatology
Open Access Poster presentation
High membrane expression of CD163 by bone marrow cells is not a 
specific marker of macrophage activation syndrome (MAS)
C Bracaglia*1, R Devito2, A Insalaco1, PS Buonuomo1, A Campana1, E Cortis1 
and AG Ugazio1
Address: 1Division of Rheumatology, Department of Pediatric Medicine; IRCCS, Ospedale Pediatrico Bambino Gesù, Rome, Italy and 2Division 
of Pathology, Department of Laboratory; IRCCS, Ospedale Pediatrico Bambino Gesù, Rome, Italy
* Corresponding author    
Background
MAS is a life-threatening complication seen predomi-
nantly in children with SoJIA, often difficult to recognize
because specific diagnostic criteria for MAS have not yet
been devised. MAS is characterized by an overwhelming
inflammatory reaction driven by excessive T cell expan-
sion and hemophagocytic macrophages. Preliminary
studies suggest that high sIL-2R α serum levels and
sCD163 might be useful as diagnostic markers for MAS.
This study assesses the expression of CD163 and CD68 in
bone marrow cells of patients with MAS and especially in
those with SoJIA who developed MAS.
Methods
Thirteen bone marrow biopsies (BMB) were performed, 7
on patients with MAS secondary to SoJIA, 6 with virus-
induced HLH. Fifteen BMB controls were included.
Immunohistochemical staining was performed using
monoclonal antibodies directed against CD163 and
CD68.
Results
CD163 immunoreactivity was characterized by a strong,
granular cytoplasmic or cytoplasmic and membrane stain-
ing pattern. The macrophage marker CD68 showed a
granular cytoplasmic pattern. Increased numbers of mac-
rophages were observed in the bone marrow of all MAS
and HLH samples. CD163 expression in macrophages was
brighter than that of CD68. CD163 expression was similar
in MAS associated with SoJIA and in virus induced HLH.
Conclusion
Our data demonstrate that CD163 in BMB is restricted to
the monocyte/macrophage lineage but is not specific for
MAS. Furthermore CD163 is similarly expressed by mac-
rophages from biopsies of both SoJIA and HLH patients.
This antibody is a marker of activated macrophages but
cannot differentiate patients with MAS from patients with
other diseases of the macrophage lineage.
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